Mikael Sigvardsson
Barbara L. Kee
Juan Carlos Zúñiga-Pflücker
Michele K. Anderson- 1BKV, Linköping University, Linköping, Sweden
- 2Division of Molecular Hemathology, Lund University, Lund, Sweden
- 3Department of Pathology, The University of Chicago, Chicago, IL, United States
- 4Department of Immunology, University of Toronto, Toronto, ON, Canada
- 5Biological Sciences, Sunnybrook Research Institute (SRI), Toronto, ON, Canada
Editorial on the Research Topic
Molecular switches of the immune system: The E protein/Id axis in hematopoietic development and function
This Frontiers in Immunology Research Topic is composed by a set of review and original articles, all highlighting the roles of E-proteins in hematopoiesis.
The first evidence for a role of E-box binding (E) proteins in the immune system came from the identification of protein bound “E-boxes” in regulatory elements at the immunoglobulin locus (1, 2). The subsequent identification of these DNA binding proteins (3) revealed amino-acid homology to MyoD as well as Myc (3, 4), and created the foundation for a new research area in molecular immunology. The complexity of the regulatory networks involving these “basic-helix-loop-helix” (bHLH) transcription factors became obvious, as both broadly expressed and tissue specific family members became identified (4). These proteins are able to form homo- as well as hetero-dimeric complexes targeting E-boxes in transcription regulatory elements of both ubiquitously expressed and tissue restricted genes (4–6). Among the broadly expressed prot*ins are E12, E47 [both encoded by the E2A gene (TCF3) (3)], HEB (TCF12) (7) and E2-2 (TCF4) (8), that due to their overlapping activities and dimerization patterns have been denoted as E proteins [Reviewed in (9)]. In aggregate, E proteins display a high degree of redundancy, and it has been proposed that functional dose, rather than expression of any specific protein, controls developmental trajectories in hematopoiesis (10–13).
The complexity of the E protein regulatory network increased with the identification of Inhibitor of DNA binding (ID) proteins (14). The ID proteins harbor the HLH domain needed for dimerization with E proteins but lack the DNA binding basic domain (b), creating a complex that is unable to bind the target DNA elements in the genome. Thus, ID proteins are powerful functional inhibitors of bHLH protein activity with important roles in hematopoiesis. This Research Topic includes a review article describing our current understanding of the function of ID proteins blood cell development (Singh et al.). The authors describe what has been learned from gain and loss of function experiments and provide insight into the intricate interplay between the different E and ID proteins in hematopoiesis.
The importance of E proteins in lymphocyte development was revealed by the targeted inactivation of the E47/E12 encoding E2A. These studies revealed a critical requirement for these E proteins at the earliest stages of lymphocyte development (15–18). This Research Topic contains a review by Aubrey et al. detailing how the complex interplay between E and ID proteins drive developmental trajectories in lymphopoiesis. The article provides a molecular insight to the mechanisms by which E proteins drive lymphoid lineage differentiation and control antigen receptor recombination to generate a functional B and T lymphocytes. An original research contribution by Roels et al. focuses on a multi-omics analysis resolving the functions of E proteins in human T-cell development. This work not only provides us with insight into the evolution of the immune system but also provides information that can be explored to better understand the role of E proteins in leukemia.
The E protein/ID protein axis is also of importance for the formation of innate lymphoid cells (ILCs) (19–25). Our current understanding of the interplay between E and ID proteins in commitment to the T lymphocyte and ILC fates is the focus of the review article by Pankow and Sun presented in this Research Topic. The role of E proteins in T cell development is complex with functional importance in early development (26, 27) as well as in the generation of effector populations in the adaptive immune response (28, 29). The article by Hidaka et al highlights this complexity by reviewing the role of E and ID proteins in early T cell development as well as in the generation of regulatory T cells.
Not only TCF3 (E2A) but also TCF12 (HEB) is reported to be of essential importance for normal T-cell development (30, 31). The use of alternative Tcf12 transcriptional start sites and alternative splicing of the transcript results in the generation of HEBCan and HEBAlt proteins. Of note, the HEBAlt protein harbors a unique N-terminal domain as compared to the HEBCan protein, and has been reported to act as a driver of early T-cell development (32, 33). In this Research Topic, an original article by Yoganathan et al. reveals that a YYY motif in the HEBAlt specific region of the protein is targeted by Janus Kinase activity. This work proposes a direct connection between E protein function and extracellular signaling events in T-cell development. Janus kinase activity is not the only signaling pathway that is functionally integrated into the E protein/ID protein axis. The review by Hwang et al. explores the signaling networks involving E- and ID proteins that control the development of T-cells as well as T-cell activation.
Among the functionally integrated signaling pathways, Notch signaling is of special interest as it is both a driver of T-cell development (34, 35) and has an important role in T-cell transformation (36, 37). Notch signaling has been reported to result in the targeting of E proteins for degradation (38, 39) suggesting that E protein dose may be directly linked to malignant transformation. The original article by Veiga et al. reports the analysis of a set of most elegant complementary T lymphocyte acute lymphoblastic leukemia (T-ALL) models revealing a unique role for TCF12 in malignant transformation. Loss and gain of function experiments provide evidence showing that a reduced TCF12 dose is redundant to NOTCH activation in the transformation process. This would indicate that targeting of TCF12 by NOTCH signaling is a major contributor to the powerful oncogenic activity exerted by NOTCH in T-ALL. In a second original article in this Research Topic, Carr et al., tested the requirements for the HMG-transcription factor LEF1, a factor previously proposed to be a component of the regulatory network involving E proteins and Notch1, in T-ALL (40). Here, they revealed that E protein deficiency promotes leukemia through adaptive mechanisms involving LEF1 addiction or independence, based on the status of LEF1 expression at the time of transformation. These papers stress the complexity by which E proteins contribute to malignant transformation, the subject of the review article by Parriott et al.. This article discusses the mechanism by which E proteins directly contribute to malignant transformation as the targets of the oncogenic bHLH proteins TAL1 and LYL1 that are overexpressed in mouse and human T-ALL.
We believe that the articles presented within the frame of this Research Topic provide timely and novel knowledge, and serve as a valuable source of information for investigators in molecular and developmental immunology.
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Acknowledgments
We wish to thank all authors and reviewers who has contributed to make this Research Topic a success.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Ephrussi A, Church GM, Tonegawa S, Gilbert W. B linage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science (1985) 227:134–40. doi: 10.1126/science.3917574
2. Church GM, Ephrussi A, Gilbert W, Tonegawa S. Cell-type-specific contacts to immunoglobulin enhancers in nuclei. Nature (1985) 313:798–801. doi: 10.1038/313798a0
3. Murre C, McCaw PS, Baltimore D. A new DNA binding and dimersation motif in immunoglobulin enhancer binding, daughterless, myoD and myc proteins. Cell (1989) 56:777–83. doi: 10.1016/0092-8674(89)90682-X
4. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 58:537–44. doi: 10.1016/0092-8674(89)90434-0
5. Murre C, Voronova A, Baltimore D. B-cell- and myocyte-specific E2-box-binding factors contain E12/E47- like subunits. Mol Cell Biol (1991) 11:1156–60. doi: 10.1128/mcb.11.2.1156-1160.1991
6. Bain G, Gruenwald S, Murre C. E2A and E2-2 are subunits of b-cell-specific E2-box DNA-binding proteins. Mol Cell Biol (1993) 13:3522–9. doi: 10.1128/mcb.13.6.3522-3529.1993
7. Hu S-J, Olson EN, Kingston RE. HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding activity of myogenic regulatory factors. Mol Cell Biol (1992) 12:1031–42. doi: 10.1128/mcb.12.3.1031-1042.1992
8. Henthorn P, Kiledjian M, Kadesch T. Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science (1990) 247:467–70. doi: 10.1126/science.2105528
9. Murre C. Helix-loop-helix proteins and the advent of cellular diversity: 30 years of discovery. Genes Dev (2019) 33:6–25. doi: 10.1101/gad.320663.118
10. Bain G, Maandag ECR, te Riele HPJ, Feeney AJ, Sheehy A, Schlissel M, et al. Both E12 and E47 allow commitment to the b cell lineage. Immunity (1997) 6:145–54. doi: 10.1016/S1074-7613(00)80421-5
11. Zhuang Y, Barndt RJ, Pan L, Kelley R, Dai M. Functional replacement of the mouse E2A gene with a human HEB cDNA. Mol Cell Biol (1998) 18:3340–9. doi: 10.1128/MCB.18.6.3340
12. Zhuang Y, Cheng P, Weintraub H. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2 and HEB. Mol Cell Biol (1996) 16:2898–905. doi: 10.1128/MCB.16.6.2898
13. Sun X-H. Constitutive expression of the Id1 gene impairs mouse b cell development. Cell (1994) 79:893–900. doi: 10.1016/0092-8674(94)90078-7
14. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein id: A negative regulator of helix-loop-helix DNA binding proteins. Cell (1990) 61:49–59. doi: 10.1016/0092-8674(90)90214-Y
15. Dias S, Mansson R, Gurbuxani S, Sigvardsson M, Kee BL. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity (2008) 29:217–27. doi: 10.1016/j.immuni.2008.05.015
16. Zhuang Y, Soriano P, Weintraub H. The helix-loop-helix gene E2A is requreid for b cell formation. Cell (1994) 79:875–84. doi: 10.1016/0092-8674(94)90076-0
17. Bain G, Maandag ECR, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, et al. E2A proteins are required for proper b cell development and initiation of immunoglobulin gene rearrangements. Cell (1994) 79:885–92. doi: 10.1016/0092-8674(94)90077-9
18. Yang Q, Kardava L, St Leger A, Martincic K, Varnum-Finney B, Bernstein ID, et al. E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors. J Immunol (2008) 181:5885–94. doi: 10.4049/jimmunol.181.9.5885
19. Verykokakis M, Krishnamoorthy V, Iavarone A, Lasorella A, Sigvardsson M, Kee BL. Essential functions for ID proteins at multiple checkpoints in invariant NKT cell development. J Immunol (2013) 191:5973–83. doi: 10.4049/jimmunol.1301521
20. D’Cruz LM, Stradner MH, Yang CY, Goldrath AW. E and id proteins influence invariant NKT cell sublineage differentiation and proliferation. J Immunol (2014) 192:2227–36. doi: 10.4049/jimmunol.1302904
21. Zook EC, Li ZY, Xu Y, de Pooter RF, Verykokakis M, Beaulieu A, et al. Transcription factor ID2 prevents e proteins from enforcing a naive T lymphocyte gene program during NK cell development. Sci Immunol (2018) 3(22):eaao2139. doi: 10.1126/sciimmunol.aao2139
22. Klose CSN, Flach M, Mohle L, Rogell L, Hoyler T, Ebert K, et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell (2014) 157:340–56. doi: 10.1016/j.cell.2014.03.030
23. Delconte RB, Shi W, Sathe P, Ushiki T, Seillet C, Minnich M, et al. The helix-Loop-Helix protein ID2 governs NK cell fate by tuning their sensitivity to interleukin-15. Immunity (2016) 44:103–15. doi: 10.1016/j.immuni.2015.12.007
24. Qian L, Bajana S, Georgescu C, Peng V, Wang HC, Adrianto I, et al. Suppression of ILC2 differentiation from committed T cell precursors by e protein transcription factors. J Exp Med (2019) 216:884–99. doi: 10.1084/jem.20182100
25. Peng V, Georgescu C, Bakowska A, Pankow A, Qian L, Wren JD, et al. E proteins orchestrate dynamic transcriptional cascades implicated in the suppression of the differentiation of group 2 innate lymphoid cells. J Biol Chem (2020) 295:14866–77. doi: 10.1074/jbc.RA120.013806
26. Bain G, Engel I, Robanus Maandag EC, te Riele HP, Voland JR, Sharp LL, et al. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol (1997) 17:4782–91. doi: 10.1128/MCB.17.8.4782
27. Yan W, Young AZ, Soares VC, Kelley R, Benezra R, Zhuang Y. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double- knockout mice. Mol Cell Biol (1997) 17:7317–27. doi: 10.1128/MCB.17.12.7317
28. Cannarile MA, Lind NA, Rivera R, Sheridan AD, Camfield KA, Wu BB, et al. Transcriptional regulator Id2 mediates CD8+ T cell immunity. Nat Immunol (2006) 7:1317–25. doi: 10.1038/ni1403
29. Yang CY, Best JA, Knell J, Yang E, Sheridan AD, Jesionek AK, et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat Immunol (2011) 12:1221–9. doi: 10.1038/ni.2158
30. D’Cruz LM, Knell J, Fujimoto JK, Goldrath AW. An essential role for the transcription factor HEB in thymocyte survival, tcra rearrangement and the development of natural killer T cells. Nat Immunol (2010) 11:240–9. doi: 10.1038/ni.1845
31. Braunstein M, Anderson MK. HEB-deficient T-cell precursors lose T-cell potential and adopt an alternative pathway of differentiation. Mol Cell Biol (2011) 31:971–82. doi: 10.1128/MCB.01034-10
32. Wang D, Claus CL, Vaccarelli G, Braunstein M, Schmitt TM, Zuniga-Pflucker JC, et al. The basic helix-loop-helix transcription factor HEBAlt is expressed in pro-T cells and enhances the generation of T cell precursors. J Immunol (2006) 177:109–19. doi: 10.4049/jimmunol.177.1.109
33. Wang D, Claus CL, Rajkumar P, Braunstein M, Moore AJ, Sigvardsson M, et al. Context-dependent regulation of hematopoietic lineage choice by HEBAlt. J Immunol (2010) 185:4109–17. doi: 10.4049/jimmunol.0901783
34. Schmitt TM, Zuniga-Pflucker JC. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity (2002) 17:749–56. doi: 10.1016/S1074-7613(02)00474-0
35. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, Bakkour S, et al. Notch1 expression in early lymphopoiesis influences b versus T lineage determination. Immunity (1999) 11:299–308. doi: 10.1016/S1074-7613(00)80105-3
36. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, et al. TAN-1, the human homolog of the drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell (1991) 66:649–61. doi: 10.1016/0092-8674(91)90111-B
37. Weng AP, Ferrando AA, Lee W, J.P.t. Morris LB, Sanchez-Irizarry C, Blacklow SC, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (2004) 306:269–71. doi: 10.1126/science.1102160
38. Nie L, Xu M, Vladimirova A, Sun XH. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J (2003) 22:5780–92. doi: 10.1093/emboj/cdg567
39. Ordentlich P, Lin A, Shen CP, Blaumueller C, Matsuno K, Artavanis-Tsakonas S, et al. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol (1998) 18:2230–9. doi: 10.1128/MCB.18.4.2230
Keywords: E-proteins, development, lymphocyte function, innate lymphoid cells, Id-proteins
Citation: Sigvardsson M, Kee BL, Zúñiga-Pflücker JC and Anderson MK (2022) Editorial: Molecular switches of the immune system: The E-protein/Id axis in hematopoietic development and function. Front. Immunol. 13:1062734. doi: 10.3389/fimmu.2022.1062734
Received: 06 October 2022; Accepted: 26 October 2022;
Published: 04 November 2022.
Edited and Reviewed by:
Andrew D. Wells, Children’s Hospital of Philadelphia, United StatesCopyright © 2022 Sigvardsson, Kee, Zúñiga-Pflücker and Anderson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mikael Sigvardsson, mikael.sigvardsson@ibk.liu.se